Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,632 total articles

Osisko Gold Announces Formal Construction Decision and Development Update for the Cariboo Gold Project

Osisko Gold Announces Formal Construction Decision and Development Update for the Cariboo Gold Project

Osisko Gold Group Inc. has officially approved the construction of its 100%-owned Cariboo Gold Project in British Columbia, targeting first gold production in Q1 2029 and commercial production by H2 2029. The project is supported by a $30 million strategic private placement and offtake agreements with Trafigura, along with a potential $120 million …

AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business

AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business

AirJoule Technologies Corporation has acquired BitSink, a U.S.-based company specializing in cooling and power distribution infrastructure for AI and high-performance computing data centers. This acquisition positions AirJoule as a broader infrastructure solutions provider, addressing critical constraints such as cooling, water, and power for next-…

VisionWave Files U.S. Non-Provisional Patent Application Describing ARGUS™, a Proposed Space-Enabled, AI-Driven Counter-Drone Defense Architecture

VisionWave Files U.S. Non-Provisional Patent Application Describing ARGUS™, a Proposed Space-Enabled, AI-Driven Counter-Drone Defense Architecture

VisionWave Holdings, Inc. announced the filing of a U.S. non-provisional patent application describing ARGUS™, a proposed space-enabled, AI-driven counter-unmanned aircraft system (C-UAS) architecture. ARGUS integrates satellite surveillance, AI-based object recognition, resilient communications, and layered defensive technologies to detect and cou…

Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification

Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification

MediWound Ltd. announced that the independent Data and Safety Monitoring Board (DSMB) recommends continuing the Phase III VALUE study of EscharEx for venous leg ulcers without any modifications, following a safety review. The company expects to complete enrollment by Q1 2027, reinforcing confidence in the drug's favorable safety profile and ongoing…

INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board

INmune Bio Inc. appointed R. Duane Clark II, a Sanofi rare-disease executive, and James Sapirstein, an experienced biopharma business development leader, to its Board of Directors. These appointments aim to bolster the company's commercialization planning for Ebstrocel™, a late-stage treatment targeting recessive dystrophic epidermolysis bullosa (R…

Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity

Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity

Corbus Pharmaceuticals announced positive topline data from its Phase 1b CANYON-1 study evaluating CRB-913 for obesity treatment. The oral CB1 inverse agonist showed statistically significant mean weight loss of 5% at 60 mg dosage after 12 weeks without weight loss plateau, and demonstrated a favorable safety and tolerability profile compared to or…

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

Senseonics Holdings announces a strategic partnership with Beta Bionics to integrate its Eversense 365 year-long continuous glucose monitor with Beta Bionics' iLet Bionic Pancreas automated insulin delivery system. The collaboration aims to commercialize a combined diabetes management solution by Q4 2026, offering enhanced ease and autonomy to pati…

Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act

Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act

Waldencast plc announced its intention to voluntarily delist its Class A Ordinary Shares and Warrants from Nasdaq by October 2026 and deregister under the Exchange Act. The company plans to rename itself Milk Makeup plc to align with its sole operating brand after selling Obagi Medical. Post-delisting, Waldencast intends to seek quotation on an ove…

Brookfield to Host 2026 Investor Day on September 17

Brookfield to Host 2026 Investor Day on September 17

Brookfield Corporation (NYSE: BN) and Brookfield Asset Management (NYSE: BAM) will hold their Investor Day event in New York on September 17, 2026, offering live webcasts and presentations to provide updates on their business operations and strategic direction. The event aims to inform investors about the company's assets under management and long-…

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

Telix Pharmaceuticals has received FDA approval for Pixclara®, a novel radioactive diagnostic PET imaging drug indicated to differentiate recurrent or progressive glioma from treatment-related changes in both adult and pediatric patients. This first FDA-approved FET-PET imaging agent for glioma offers physicians enhanced diagnostic precision and tr…

Parsons Operational, Agile, Defense Solutions Ready Now on Department of War’s Digital Marketplaces

Parsons Operational, Agile, Defense Solutions Ready Now on Department of War’s Digital Marketplaces

Parsons Corporation announced that nine of its digital defense solutions have been designated as 'Awardable' across two major Department of War digital marketplaces, Platform One and Tradewinds. This recognition facilitates faster government procurement and deployment of Parsons' innovative, mission-ready defense technologies, enhancing operational…

Cespira™, the Joint Venture between Westport and Volvo Group, reveals how HPDI™ 3.0 advances fuel economy and expands OEM options

Cespira™, the Joint Venture between Westport and Volvo Group, reveals how HPDI™ 3.0 advances fuel economy and expands OEM options

Westport Fuel Systems and Volvo Group's joint venture, Cespira, announced the advanced HPDI 3.0 fuel system that improves fuel economy, hardware durability, and system integration for heavy-duty engines using LNG and bioLNG. The technology supports broader engine configurations and future fuels like hydrogen, with production beginning in late 2026 …